References
- Pizzi LT, Weston CM, Goldfarb NI, Moretti D, Cobb N, Howell JB, Impact of chronic conditions on quality of life in patients with inflammatory bowel disease. Inflamm Bowel Dis 2006;12:47–52.
- Wells CW, Lewis S, Barton JR, Corbett S. Effects of changes in haemoglobin level on quality of life and cognitive function in inflammatory bowel disease patients. Inflamm Bowel Dis 2006;12:123–30.
- Gasche C, Berstad A, Befrits R, Beglinger C, Dignass A, Erichsen K, Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel disease. Inflamm Bowel Dis 2007;13:1545–53.
- Gasche C. Anemia in inflammatory bowel diseases. Bremen: UNI-MED Verlag AG; 2008.
- Kulnigg S, Gasche C. Systematic review: managing anaemia in Crohn's disease. Aliment Pharmacol Ther 2006;24:1507–23.
- Gisbert PJ, Gomollon F. Common misconceptions in the diagnosis and management of anemia in inflammatory bowel disease. Am J Gastroenterol 2008;103:1299–307.
- Lindgren S, Wikman O, Befrits R, Blom H, Eriksson A, Grännö C, Intravenous iron sucrose is superior to oral iron sulphate for correcting anaemia and restoring iron stores in IBD patients: a randomized, controlled, evaluator-blind, multicentre study. Scand J Gastroenterol 2009;44:838–45.
- Kulnigg S, Stoinov S, Simanenkov V, Dudar LV, Karnafel W, Garcia LC, A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (Ferinject®) randomized controlled trial. Am J Gastroenterol 2008;103:1182–92.
- Gasche C. Anemia in IBD: the overlooked villain. Inflamm Bowel Dis 2000;6:142–150.
- Rockey DC. Treatment of iron deficiency. Gastroenterology 2006;130:1367–8.
- Gasche C, Lomer MC, Cavill I, Weiss G. Iron, anaemia, and inflammatory bowel diseases. Gut 2004;53:1190–7.
- Erichsen K. Iron therapy in inflammatory bowel disease. Thesis. Bergen: University of Bergen; 2005.
- Vijverman A, Piront P, Belaiche J, Louis E. Evolution of the prevalence and characteristics of anemia in inflammatory bowel diseases between 1993 and 2003. Acta Gastroenterol Belg 2006;69:1–4.
- Wilson A, Reyes E, Ofman J. Prevalence and outcomes of anemia in inflammatory bowel disease: a systematic review of literature. Am J Med 2004;116:44–9.
- Bergamaschi G, Di Sabatino A, Albertini R, Ardizzone S, Biancheri P, Bonetti E, Prevalence and pathogenesis of anemia in inflammatory bowel disease. Influence of anti-tumor necrosis factor-α treatment. Haematologia 2010;2:199–205.
- Harvey RF, Bradshaw JM. A simple index of Crohn's-disease activity. Lancet 1980;314:514.
- Walmsley RS, Ayres RCS, Pounder RE, Allan RN. A simple clinical colitis activity index. Gut 1998;43:29–32.
- WHO/UNICEF/UNU. Iron deficiency anemia: assessment, prevention and control. Report of a joint WHO/UNICEF/UNU consultation. Geneva: World Health Organization; 1998.
- Weiss G, Gasche C. Pathogenesis and treatment of anemia in inflammatory bowel disease. Haematologia 2010;2:175–8.
- Busbridge M, Griffiths C, Ashby D, Gale D, Jayantha A, Sanwaiya A, Development of a novel immunoassay for the iron regulatory peptide hepcidin. Br J Biomed Sci 2009;66:150–7.
- Cheng PP, Jiao XY, Lin JH, Cai YM. Hepcidin expression in anaemia of chronic disease and concomitant iron-deficiency anemia. Clin Exp Med; May 25. (Epub ahead of print).
- Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK, IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 2004;113:1271–6.
- Nemeth E, Ganz T. The role of hepcidin in iron metabolism. Acta Haematol 2009;122:78–86.
- Kulnigg S, Teischinger L, Dejaco C, Waldhör T, Gasche C. Rapid recurrence of IBD-associated anemia and iron deficiency after intravenous iron sucrose and erythropoietin treatment. Am J Gastroenterol 2009;104:1460–7.